Dextran 75
Dextran 75
Approved
Approval ID
a71129ae-8266-4064-a3f5-6f2897e62981
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 1, 2012
Manufacturers
FDA
AnazaoHealth Corporation
DUNS: 011038762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dextran 75
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51808-210
Product Classification
G
Generic Name
Dextran 75
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 2, 2012
FDA Product Classification
INGREDIENTS (4)
DEXTRAN 75Active
Quantity: 10 mg in 1 1
Code: JY83SHX053
Classification: ACTIB
ANHYDROUS DEXTROSEInactive
Quantity: 1 mg in 1 1
Code: 5SL0G7R0OK
Classification: IACT
STANNOUS CHLORIDEInactive
Quantity: 0.3 mg in 1 1
Code: 1BQV3749L5
Classification: IACT
SODIUM CITRATEInactive
Quantity: 0.73 mg in 1 1
Code: 1Q73Q2JULR
Classification: IACT
Drug Labeling Information
SPL UNCLASSIFIED SECTION
LOINC: 42229-5Updated: 7/23/2012
Dear Medical Professional,
Per your order, we have compounded Dextran 75 as a lyophilized powder for injection. The characteristics of this preparation are as follows: